CHANGE IN CONTROL SEVERANCE AGREEMENT BETWEENSeverance Agreement • November 5th, 2021 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia
This Change in Control Severance Agreement (this “Agreement”) is entered into between Alimera Sciences, Inc., a Delaware corporation (together with its subsidiaries, the “Company”), and Philip J. Ashman, Ph.D. (“Executive”), as of July 16, 2021 (the “Effective Date”).
